MEREDITH GILPIN: Open Payments
NPI 1013491281 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 26 payments from 15 companies in 2025. Trend: 2023 $664 · 2024 $239 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $113 |
| Janssen Biotech, Inc. | 4 | $69 |
| Endo USA, Inc. | 2 | $52 |
| UROGEN PHARMA, INC. | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| BIOPROTECT MEDICAL, INC. | 1 | $38 |
| Astellas Pharma US Inc | 2 | $37 |
| Olympus America Inc. | 1 | $27 |
| AngioDynamics, Inc. | 1 | $26 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $25 |
Products named: GEMTESA, XTANDI, ERLEADA, BIOPROTECT BALLOON IMPLANT SYSTEM, Bovie, XIAFLEX, NANOKNIFE, AVEED.
Industry payments across KY — which companies pay providers there.
